Cited by — Abstract No: 355 TO EVALUATE THE EFFICACY AND SAFETY OF TELITACICEPT AND STANDARD TREATMENT FOR 6MONTHS IN IGA NEPHROPATHY, SINGLE CENTER, RANDOMIZED, OPEN LABEL, COMPARATIVE STUDY | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Abstract No: 355 TO EVALUATE THE EFFICACY AND SAFETY OF TELITACICEPT AND STANDARD TREATMENT FOR 6MONTHS IN IGA NEPHROPATHY, SINGLE CENTER, RANDOMIZED, OPEN LABEL, COMPARATIVE STUDY.
No admitted local citation edges point to this work yet.
